Literature DB >> 8428202

Functional characterization of a 5-HT3 receptor which modulates the release of 5-HT in the guinea-pig brain.

P Blier1, C Bouchard.   

Abstract

1. The aims of the present study were to confirm the modulation by 5-HT3 receptors of the electrically evoked release of tritium from slices preloaded with [3H]-5-HT of guinea-pig frontal cortex, hippocampus and hypothalamus, and to assess their functional role in 5-HT release. 2. The selective 5-HT3 agonist, 2-methyl-5-HT, introduced 8 min before the electrical stimulation, enhanced in a concentration-dependent manner the evoked release of [3H]-5-HT in the three brain regions studied. The 5-HT3 agonists, phenylbiguanide and m-chlorophenyl-biguanide, did not enhance the release of tritium in frontal cortex and hypothalamus slices. 3. In hypothalamus slices, this response was lost when 2-methyl-5-HT was introduced 20 min before the stimulation, thus indicating that these 5-HT3 receptors desensitize rapidly. When 2-methyl-5-HT was added 20-min before the first stimulation period to desensitize the 5-HT3 receptors, removed for 24 min, and then re-introduced 8 min before the second stimulation period, the enhancing effect of 2-methyl-5-HT was restored, thus indicating that these 5-HT3 receptors can rapidly regain normal sensitivity. 4. The enhancing effect of 2-methyl-5-HT was attenuated by the 5-HT3 receptor antagonists m-chloro-phenylpiperazine = quipazine = ondansetron > or = ICS 205-930 = BRL 24924 > MDL 72222 = zacopride. 5. The 5-HT reuptake blocker, paroxetine, enhanced the electrically evoked release of tritium when introduced 8 min before stimulation; this effect of paroxetine was blocked by ICS 205-930, thus indicating that these 5-HT3 receptors can be activated by endogenous 5-HT. 6. In the absence of electrical stimulation, 2-methyl-5-HT (10 microM) produced a marked enhancement of the basal release of [3H]-5-HT which was calcium-dependent and blocked by S-zacopride but not by paroxetine. 7. The enhancing effect of 2-methyl-5-HT was dependent both on the frequency of stimulation, as indicated by the attenuated effect of 120 stimulations delivered at 1 Hz instead of 5 Hz, and on the duration of the stimulation, as indicated by the more pronounced effect of pulses delivered at 5 Hz for 24 s instead of 72 s or 120 s.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428202      PMCID: PMC1907691          DOI: 10.1111/j.1476-5381.1993.tb13433.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex.

Authors:  M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

2.  Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.

Authors:  S Z Langer; C Moret
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

3.  5-HT3 receptors are not involved in the modulation of the K(+)-evoked release of [3H]5-HT from spinal cord synaptosomes of rat.

Authors:  G M Williams; D L Smith; D J Smith
Journal:  Neuropharmacology       Date:  1992-08       Impact factor: 5.250

4.  Nicotinic stimulation of [3H]acetylcholine release from mouse cerebral cortical synaptosomes.

Authors:  P P Rowell; D L Winkler
Journal:  J Neurochem       Date:  1984-12       Impact factor: 5.372

5.  5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release.

Authors:  G Maura; G C Andrioli; P Cavazzani; M Raiteri
Journal:  J Neurochem       Date:  1992-06       Impact factor: 5.372

6.  Effect of repeated electroconvulsive shocks on serotonergic neurons.

Authors:  P Blier; C Bouchard
Journal:  Eur J Pharmacol       Date:  1992-02-18       Impact factor: 4.432

7.  Terminal serotonin autoreceptor function in the rat hippocampus is not modified by pertussis and cholera toxins.

Authors:  P Blier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

8.  mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors.

Authors:  D W Robertson; W Bloomquist; D T Wong; M L Cohen
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

9.  Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in rat hippocampus in vivo.

Authors:  K F Martin; S Hannon; I Phillips; D J Heal
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

10.  Evidence that the 5-HT3 receptors of the rat, mouse and guinea-pig superior cervical ganglion may be different.

Authors:  N R Newberry; S H Cheshire; M J Gilbert
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

View more
  7 in total

Review 1.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

2.  Functional characterization of 5-HT1D autoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe, hippocampus and frontal cortex.

Authors:  M el Mansari; P Blier
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

3.  Effects of dorsal rhizotomy and selective lesion of serotonergic and noradrenergic systems on 5-HT1A, 5-HT1B, and 5-HT3 receptors in the rat spinal cord.

Authors:  A M Laporte; C M Fattaccini; M C Lombard; J Chauveau; M Hamon
Journal:  J Neural Transm Gen Sect       Date:  1995

4.  A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction.

Authors:  Laszlo G Harsing; Ibolya Prauda; Jozsef Barkoczy; Peter Matyus; Zsolt Juranyi
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

5.  Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.

Authors:  P Blier; C Bouchard
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

6.  The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat.

Authors:  L G Harsing
Journal:  Curr Neuropharmacol       Date:  2006-10       Impact factor: 7.363

7.  5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo.

Authors:  J Ge; N M Barnes
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.